相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic
Hugh Adler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
Lois A. Privor-Dumm et al.
VACCINE (2021)
Influenza-like Illness Exacerbates Pneumococcal Carriage in Older Adults
Willem R. Miellet et al.
CLINICAL INFECTIOUS DISEASES (2021)
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease Among Adults With and Without Underlying Medical Conditions-United States
Sana S. Ahmed et al.
CLINICAL INFECTIOUS DISEASES (2020)
Long-term Impact of Pneumococcal Conjugate Vaccines on Invasive Disease and Pneumonia Hospitalizations in Indigenous and Non-Indigenous Australians
Kelley N. Meder et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013-18
Harry Pick et al.
THORAX (2020)
Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia
Christina Forstner et al.
VACCINE (2020)
Association between sarcopenia and pneumonia in older people
Tatsuma Okazaki et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2020)
Upper respiratory tract colonization withStreptococcus pneumoniaein adults
Adriano Arguedas et al.
EXPERT REVIEW OF VACCINES (2020)
Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study
A. Vila-Corcoles et al.
LUNG (2020)
The World Health Organization (WHO) approach to healthy ageing
Ewa Rudnicka et al.
MATURITAS (2020)
Extracellular adenosine signaling reverses the age-driven decline in the ability of neutrophils to killStreptococcus pneumoniae
Manmeet Bhalla et al.
AGING CELL (2020)
Single-cell analyses of aging, inflammation and senescence
Bora Uyar et al.
AGEING RESEARCH REVIEWS (2020)
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
Jason LeBlanc et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands
Bradford D. Gessner et al.
VACCINE (2019)
Decline in Pneumococcal Disease Attenuated in Older Adults and Those With Comorbidities Following Universal Childhood PCV13 Immunization
Stephen I. Pelton et al.
CLINICAL INFECTIOUS DISEASES (2019)
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis
Nirma Khatri Vadlamudi et al.
VACCINE (2019)
Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States
John M. McLaughlin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion
T. Mark Doherty et al.
ANNALS OF MEDICINE (2019)
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia
Raul E. Isturiz et al.
VACCINE (2019)
Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Mark van der Linden et al.
PLOS ONE (2019)
A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands
Bradford D. Gessner et al.
VACCINE (2019)
Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis
John M. McLaughlin et al.
VACCINE (2019)
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
Almea Matanock et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
2718. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in US Adults Hospitalized with Pneumonia, 2014–2017
Fernanda C Lessa et al.
Open Forum Infectious Diseases (2019)
2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
Ned Lewis et al.
Open Forum Infectious Diseases (2019)
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on the Incidence of All-cause Pneumonia in Adults Aged ≥60 Years: A Population-based, Retrospective Cohort Study
Martin Kolditz et al.
CLINICAL INFECTIOUS DISEASES (2019)
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
Germaine Hanquet et al.
THORAX (2019)
Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae
Elisa Ramos-Sevillano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mechanisms underlying T cell ageing
Jorg J. Goronzy et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Influence of Older Age and Other Risk Factors on Pneumonia Hospitalization in Switzerland in the Pneumococcal Vaccine Era
Werner C. Albrich et al.
FRONTIERS IN MEDICINE (2019)
Efficacy and Safety of the Pneumococcal Conjugate-13 Valent Vaccine in Adults
Fawziah Marra et al.
AGING AND DISEASE (2019)
Human B-1 Cells and B-1 Cell Antibodies Change With Advancing Age
Nely Rodriguez-Zhurbenko et al.
FRONTIERS IN IMMUNOLOGY (2019)
NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection
Soo Jung Cho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
Paraskevi F. Farmaki et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
Shamez N. Ladhani et al.
LANCET INFECTIOUS DISEASES (2018)
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review
Antoni Torres et al.
RESPIRATORY MEDICINE (2018)
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015
Pernille Jorgensen et al.
VACCINE (2018)
A report on the status of vaccination in Europe
Shazia Sheikh et al.
VACCINE (2018)
Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England andWales
Abdelmajid Djennad et al.
ECLINICALMEDICINE (2018)
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
Raul Isturiz et al.
EXPERT REVIEW OF VACCINES (2017)
Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens
Robert Wilson et al.
PLOS PATHOGENS (2017)
Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease
Rebecca Bornheimer et al.
PLOS ONE (2017)
Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality
Julio A. Ramirez et al.
CLINICAL INFECTIOUS DISEASES (2017)
Immune ageing and susceptibility to Streptococcus pneumoniae
Mariana Torrente Goncalves et al.
BIOGERONTOLOGY (2016)
Reduced mucociliary clearance in old mice is associated with a decrease in Muc5b mucin
Barbara R. Grubb et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Severity Assessment and the Immediate and Long-Term Prognosis in Community-Acquired Pneumonia
Martin Kolditz et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
Wen-qi Diao et al.
VACCINE (2016)
TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity
Alicja Puchta et al.
PLOS PATHOGENS (2016)
Rates of pneumonia among children and adults with chronic medical conditions in Germany
Stephen I. Pelton et al.
BMC INFECTIOUS DISEASES (2015)
The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly
Cornelis H. van Werkhoven et al.
CLINICAL INFECTIOUS DISEASES (2015)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Burden and Etiology of Community-Onset Pneumonia in the Aging Japanese Population: A Multicenter Prospective Study
Konosuke Morimoto et al.
PLOS ONE (2015)
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Lorry G. Rubin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Aging disturbs the balance between effector and regulatory CD4+T cells
Kornelis S. M. van der Geest et al.
EXPERIMENTAL GERONTOLOGY (2014)
Elevated A20 contributes to age-dependent macrophage dysfunction in the lungs
Cecilia A. Hinojosa et al.
EXPERIMENTAL GERONTOLOGY (2014)
Role of dendritic cells in innate and adaptive immune response in human aging
Sudhir Gupta
EXPERIMENTAL GERONTOLOGY (2014)
Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions
Cassandra L. Krone et al.
LANCET RESPIRATORY MEDICINE (2014)
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
Kimberly M. Shea et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Aging, Diabetes, and Hypertension Are Associated With Decreased Nasal Mucociliary Clearance
Janaina Proenca de Oliveira-Maul et al.
CHEST (2013)
Long-term prognosis in community-acquired pneumonia
Marcos I. Restrepo et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
Glycoconjugate vaccines
David Pace
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Impaired Innate Mucosal Immunity in Aged Mice Permits Prolonged Streptococcus pneumoniae Colonization
Cassandra L. Krone et al.
INFECTION AND IMMUNITY (2013)
Acute pneumonia and the cardiovascular system
Vicente F. Corrales-Medina et al.
LANCET (2013)
Age-related defects in TLR2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia
Angela R. Boyd et al.
EXPERIMENTAL GERONTOLOGY (2012)
Enumeration of human peripheral blood dendritic cells throughout the life
Giulia Orsini et al.
INTERNATIONAL IMMUNOLOGY (2012)
The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
Albert Jan van Hoek et al.
JOURNAL OF INFECTION (2012)
Advanced Age Impairs Macrophage Polarization
Shegufta Mahbub et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2012)
Clinical and economic burden of community-acquired pneumonia among adults in Europe
T. Welte et al.
THORAX (2012)
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia
Thomas Bewick et al.
THORAX (2012)
Age-related changes in human peripheral blood IGH repertoire following vaccination
Yu-Chang Bryan Wu et al.
FRONTIERS IN IMMUNOLOGY (2012)
Age-associated increase in heterochromatic marks in murine and primate tissues
Jill A. Kreiling et al.
AGING CELL (2011)
Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia
Pooja Shivshankar et al.
AGING CELL (2011)
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
Jan Poolman et al.
EXPERT REVIEW OF VACCINES (2011)
Older Adults Have a Low Capacity To Opsonize Pneumococci Due to Low IgM Antibody Response to Pneumococcal Vaccinations
Saeyoung Park et al.
INFECTION AND IMMUNITY (2011)
Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis
Birgit Simell et al.
VACCINE (2011)
Impaired Functions of Peripheral Blood Monocyte Subpopulations in Aged Humans
Joseph Nyugen et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Age-Associated Inflammation and Toll-Like Receptor Dysfunction Prime the Lungs for Pneumococcal Pneumonia
Ernesto Hinojosa et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
Tom van der Poll et al.
LANCET (2009)
The aging of the immune system
Daniela Weiskopf et al.
TRANSPLANT INTERNATIONAL (2009)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins
Birgit Simell et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia
Julio Ramirez et al.
CLINICAL INFECTIOUS DISEASES (2008)
Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired Pneumonia A Population-Based Cohort Study
Jennie Johnstone et al.
MEDICINE (2008)
Interleukin-17A mediates acquired immunity to pneumococcal colonization
Ying-Jie Lu et al.
PLOS PATHOGENS (2008)
Aging and T-cell diversity
Jorg J. Goronzy et al.
EXPERIMENTAL GERONTOLOGY (2007)
Influence of comorbid conditions on long-term mortality after pneumonia in older people
Sachin Yende et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Age-associated defect in human TLR-1/2 function
David van Duin et al.
JOURNAL OF IMMUNOLOGY (2007)
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
Claudio Franceschi et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2007)
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide
R Malley et al.
INFECTION AND IMMUNITY (2006)
Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia
S Yende et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model
K Trzcinski et al.
INFECTION AND IMMUNITY (2005)
Long-term clearance from small airways decreases with age
M Svartengren et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Hospitalization for pneumonia in the cardiovascular health study: Incidence, mortality, and influence on longer-term survival
ES O'Meara et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
The influence of age on T cell generation and TCR diversity
K Naylor et al.
JOURNAL OF IMMUNOLOGY (2005)
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization
R Malley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Aspiration and infection in the elderly - Epidemiology, diagnosis and management
M Kikawada et al.
DRUGS & AGING (2005)
Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell
YH Shi et al.
JOURNAL OF IMMUNOLOGY (2005)
Inflammatory mediators in the elderly
KS Krabbe et al.
EXPERIMENTAL GERONTOLOGY (2004)
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen
S Kruetzmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Premature ageing of the immune system: the cause of AIDS?
V Appay et al.
TRENDS IN IMMUNOLOGY (2002)
Cutting edge: Impaired toll-like receptor expression and function in aging
M Renshaw et al.
JOURNAL OF IMMUNOLOGY (2002)
B-1 cells: orthodox or conformist?
IH Su et al.
CURRENT OPINION IN IMMUNOLOGY (2000)
Efficacy of pneumococcal conjugate vaccines in large scale field trials
HR Shinefield et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
分享论文
